Abstract
Objectives The aim of this study was to identify the prevalence and characteristics of treatment related problems (TRPs) in hospitalized internal medicine patients in Jordan as well as to identify diseases and drugs associated with each specific TRP. We have also aimed at investigating physicians’ acceptance of recommendations made by clinical pharmacist and to identify the outcomes of pharmacist interventions. Setting Internal medicine department of a general hospital in Jordan. Methods We have utilized a systematic, prospective, bedside, comprehensive clinical assessment approach that allowed us to effectively identify, communicate and follow up TRPs. Main outcome measures: prevalence and nature of identified TRPs, clinical significance of TRPs, associated diseases and drugs and clinical outcomes of clinical pharmacist interventions. Results 402 patients were included in the study. The average number of the identified TRPs was 9.35. Fifty-three percent of identified TRPs were classified as major and 28% were classified as moderate. Ninety-one percent of the recommendations were accepted by physicians. Efficacy related problems were the most common TRP category followed by safety related problems and indication related problems. Sixty-four percent of the TRPs were resolved or prevented through the clinical pharmacist intervention. Conclusions We have found that prevalence of TRPs is substantially high among patients hospitalized at the internal medicine department. TRPs related to Dosage regimens, untreated conditions, patient monitoring, drug interactions, and drug choices were the most common. Most of TRPs identified by pharmacists were clinically significant. Pharmacists’ interventions contributed substantially to the resolving of many of the identified TRPs. Patients suffering from higher number of medical conditions and receiving higher number of medications should be given the priority for clinical pharmacy service in hospitalized internal medicine patients.
Similar content being viewed by others
References
Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41(2):192–9.
Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000. ISBN: 0-309-06837-1.
Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care. 2000;38(3):261–71.
Thomas EJ, Studdert DM, Newhouse JP, et al. Costs of medical injuries in Utah and Colorado. Inquiry. 1999;36(3):255–64.
Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324(6):370–6.
Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377–84.
Lagnaoui R, Moore N, Fach J, et al. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol. 2000;56(2):181–6.
Winterstein AG, Sauer BC, Hepler CD, et al. Preventable drug-related hospital admissions. Ann Pharmacother. 2002;36(7–8):1238–48.
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5.
Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19(5):556–64.
Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009;34(3):319–27.
Rao D, Gilbert A, Strand LM, et al. Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci. 2007;29(6):647–54.
Lewis NJ, Bugdalski-Stutrud C, Abate MA, et al. The medication assessment program: comprehensive medication assessments for persons taking multiple medications for chronic diseases. J Am Pharm Assoc. 2008;48(2):171–80.
Blix HS, Viktil KK, Reikvam A, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60(9):651–8.
Viktil KK, Blix HS, Reikvam A, et al. Comparison of drug-related problems in different patient groups. Ann Pharmacother. 2004;38(6):942–8.
De Rijdt T, Willems L, Simoens S. Economic effects of clinical pharmacy interventions: a literature review. Am J Health Syst Pharm. 2008;65(12):1161–72.
Stafford AC, Tenni PC, Peterson GM, et al. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Sci. 2009;31(2):216–23.
Vessal G. Detection of prescription errors by a unit-based clinical pharmacist in a nephrology ward. Pharm World Sci. 2010;32:59–65.
Welch EK, Delate T, Chester EA, et al. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries. Ann Pharmacother. 2009;43(4):603–10.
Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother. 2009;43(6):1096–106.
Chap L. Study designs. In: Chap L, editor. Introductory biostatistics. 1st ed. Hoboken, NJ: Wiley; 2003. p. 445. ISBN: 978-0471418160.
AbuRuz SM, Bulatova NR, Yousef AM. Validation of a comprehensive classification tool for treatment-related problems. Pharm World Sci. 2006;28(4):222–32.
AbuRuz SM, Bulatova NR, Yousef AM. Pharmaceutical care manual. Jordan National library; 2007. Copyright number 2007/12/3856.
AbuRuz SM. The case for evidence based pharmaceutical care. Research in Social and Administrative Pharmacy (in press). doi: 10.1016/j.sapharm.2009.06.001.
Cipolle RJ, Strand L, Morley P. Pharmaceutical care practice: the clinician’s guide. 2nd ed. New York: McGraw-Hill; 2004. ISBN: 978-0071362597.
Lacy CF, Armstrong LL. Goldman MP, Lance LL. Lexi-comp’s drug information handbook. 14th ed. Hudson, Oh: Lexi-Comp, Inc.; 2006. ISBN: 978-1591951063.
The I-Facts. Facts and comparisons drug interactions facts. St. Louis, MO: Wolters Kluwer Health; 2006. ISBN: 978-0932686480.
Dodd C. Assessing pharmacy intervention at Salisbury Health Care NHS trust. Hosp Pharm. 2006;10:451–6.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
Szumita PM. The hospital pharmacist: an integral part of the hyperglycaemic management team. J Clin Pharm Ther. 2009;34:613–21.
Petrie JL, Segal AR. Clinical pharmacy services provided to asthma patients in a school-based clinic. Am J Health Syst Pharm. 2010; 67(3):185, 188-9.
Bedouch P, Allenet B, Grass A. Drug-related problems in medical wards with a computerized physician order entry system. J Clin Pharm Ther. 2009;34(2):187–95.
Koh Y, Kutty FB, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39–48.
Dashti-Khavidaki S, Khalili H, Hamishekar H, et al. Clinical pharmacy services in an Iranian teaching hospital: a descriptive study. Pharm World Sci. 2009;31(6):696–700.
Pastakia SD, Schellhase EM, Jakait B. Collaborative partnership for clinical pharmacy services in Kenya. Am J Health Syst Pharm. 2009;66(15):1386–90.
de Lyra DP, Kheir N, Abriata JP, et al. Impact of pharmaceutical care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirao Preto (SP), Brazil. Ther Clin Risk Manag. 2007;3(6):989–98.
Sadik A, Yousif M, McElnay JC. Pharmaceutical care of patients with heart failure. Br J Clin Pharmacol. 2005;60(2):183–93.
Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus. Br J Clin Pharmacol. 2009;67(5):547–57.
Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997;277(4):312–7.
Lipton HL, Bero LA, Bird JA, et al. The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing. A randomized controlled trial. Med Care. 1992;30(7):646–58.
Alderman CP, Farmer C. A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract. 2001;21(4):99–103.
Barber ND, Batty R, Ridout DA. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm. 1997;54(4):397–405.
Hanlon JT, Fillenbaum GG, Schmader KE, et al. Inappropriate drug use among community-dwelling elderly. Pharmacotherapy. 2000;20(5):575–82.
Flaherty JH, Perry HM, Lynchard GS, et al. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000;55(10):M554–9.
Gilbert AL, Roughead EE, Beilby J, et al. Collaborative medication management services: improving patient care. Med J Aust. 2002;177(4):189–92.
Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med. 2002;162(15):1670–2.
Acknowledgment
The authors wish to thank all patients, pharmacists and physicians who contributed to the success of this work.
Funding
The authors wish to acknowledge the Deanship of Academic Research at the University of Jordan for funding this research which was part of the “Pharmaceutical Care Project in Jordan”.
Conflicts of interest
The authors declare that they have no conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
AbuRuz, S.M., Bulatova, N.R., Yousef, AM.M. et al. Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan. Int J Clin Pharm 33, 501–511 (2011). https://doi.org/10.1007/s11096-011-9497-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-011-9497-y